Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Jessica Hong

1PUBLICATIONS

11CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|May 02, 2022

Development of Highly Effective Anti-Mesothelin hYP218 Chimeric Antigen Receptor T Cells With Increased Tumor Infiltration and Persistence for Treating Solid Tumors.

Sakshi Tomar, Jingli Zhang, Manakamana Khanal

Pageof 1

Frequent Collaborators

1 joint publications

Sakshi Tomar

1 joint publications

Jingli Zhang

1 joint publications

Manakamana Khanal

1 joint publications

Abhilash Venugopalan

1 joint publications

Qun Jiang

1 joint publications

Manjistha Sengupta

1 joint publications

Markku Miettinen

1 joint publications

Nan Li

1 joint publications

Ira Pastan

1 joint publications

Mitchell Ho

Frequent Collaborators

1 joint publications

Sakshi Tomar

1 joint publications

Jingli Zhang

1 joint publications

Manakamana Khanal

1 joint publications

Abhilash Venugopalan

Top Related Videos

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on : Feb 21, 2025

See more related videos

Top Related Videos

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on : Feb 21, 2025

See more related videos